(19)
(11) EP 4 816 064 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24827808.7

(22) Date of filing: 29.11.2024
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
C07K 16/40(2006.01)
C07K 14/52(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/505; A61P 35/00; C07K 16/40; C07K 2317/24; C07K 2317/33; C07K 2317/92; C07K 2319/33; C07K 2319/00; C07K 14/70575; C12N 9/50
(86) International application number:
PCT/CN2024/135694
(87) International publication number:
WO 2025/113643 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 WO PCT/CN2023/135902
12.11.2024 WO PCT/CN2024/131641

(71) Applicant: Gilead Sciences Inc.
Foster City, California 94404 (US)

(72) Inventors:
  • ZHAI, Qianting
    Shanghai 200233 (CN)
  • FEI, Mingjian
    Shanghai 200233 (CN)
  • CAO, Jun
    Shanghai 200233 (CN)
  • SUN, Runzi
    Shanghai 200233 (CN)
  • LI, Lixue
    Shanghai 200233 (CN)
  • ZHU, Hui
    Shanghai 200233 (CN)

(74) Representative: Schnappauf, Georg 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) ANTI-FAP-LIGHT FUSION PROTEIN AND USE THEREOF